Kate Ackley wrote a great story about the most recent attempt to create a regulatory approval process for generic biotechnology medications on the Hill.
In his latest Examiner column, Tim Carney looks at hedge fund manager Julian Robertson’s lobbying for cap-and-trade legislation and bet on a U.S. economic…
Certainly not the UN! The debate, such as it is, over global warming has been increasingly driven by the Intergovernmental Panel on Climate Change. The…
